Innovation Pharmaceuticals (OTCMKTS:IPIX) Stock Price Down 3.9%

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX)’s stock price traded down 3.9% during trading on Wednesday . The company traded as low as $0.23 and last traded at $0.24. 1,251,344 shares changed hands during trading, a decline of 28% from the average session volume of 1,736,992 shares. The stock had previously closed at $0.25.

The company has a fifty day moving average price of $0.21.

Innovation Pharmaceuticals Company Profile (OTCMKTS:IPIX)

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.

Read More: How a Strangle Strategy is different from a Straddle Strategy

Receive News & Ratings for Innovation Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovation Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.